A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/425 (2006.01)
Patent
CA 2565384
The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.
L'invention concerne des méthodes et des compositions destinées au traitement d'états associés à la phospholipase. L'invention concerne en particulier une méthode de traitement d'états associés à l'insuline, au poids et/ou des états associés au cholestérol chez un sujet animal. La méthode de l'invention consiste généralement à administrer un inhibiteur de phospholipase A2 non absorbé et/ou résultant d'un écoulement qui est localisé dans une lumière gastro-intestinale.
Buysse Jerry M.
Chang Han Ting
Charmot Dominique
Cope Michael James
Hui David
Ilypsa Inc.
Ridout & Maybee Llp
LandOfFree
Phospholipase inhibitors localized in the gastrointestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase inhibitors localized in the gastrointestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase inhibitors localized in the gastrointestinal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1589407